Cargando…
Cystic Fibrosis Transmembrane Conductance Regulator Genotype, Not Circulating Catecholamines, Influences Cardiovascular Function in Patients with Cystic Fibrosis
BACKGROUND: Cystic fibrosis (CF) is a genetic disease affecting multiple organ systems of the body and is characterized by mutation in the gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR). Previous work has shown that a single dose of aβ-agonist increases cardiac output...
Autores principales: | Bisch, Alexander L, Wheatley, Courtney M, Baker, Sarah E, Peitzman, Elizabeth R, Van Iterson, Erik H, Laguna, Theresa A, Morgan, Wayne J, Snyder, Eric M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442074/ https://www.ncbi.nlm.nih.gov/pubmed/30956528 http://dx.doi.org/10.1177/1179548419835788 |
Ejemplares similares
-
Impaired cardiac and peripheral hemodynamic responses to inhaled β(2)-agonist in cystic fibrosis
por: Van Iterson, Erik H., et al.
Publicado: (2015) -
Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectives
por: Schmidt, Béla Z, et al.
Publicado: (2016) -
The Extrapulmonary Effects of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Cystic Fibrosis
por: Sergeev, Valentine, et al.
Publicado: (2020) -
The Coupling of Peripheral Blood Pressure and Ventilatory Responses during Exercise in Young Adults with Cystic Fibrosis
por: Van Iterson, Erik H., et al.
Publicado: (2016) -
Exercise Stroke Volume in Adult Cystic Fibrosis: A Comparison of Acetylene Pulmonary Uptake and Oxygen Pulse
por: Van Iterson, Erik H, et al.
Publicado: (2018)